comparemela.com

Kronos Bio, Inc. (NASDAQ:KRON – Get Free Report) CEO Norbert W. Bischofberger acquired 1,378,901 shares of the business’s stock in a transaction that occurred on Monday, June 10th. The shares were acquired at an average cost of $0.88 per share, with a total value of $1,213,432.88. Following the transaction, the chief executive officer now directly […]

Related Keywords

United States , Kronos Bio , Norbertw Bischofberger , Acuta Capital Partners , Nasdaq , Marquette Asset Management , Cerity Partners , Kronos Bio Company Profile , Virtu Financial , Acadian Asset Management , Securities Exchange Commission , Kronos Bio Inc , Get Free Report , Exchange Commission , Asset Management , Capital Partners , Kronos Bio Daily ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.